SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B4 - Prospectus [Rule 424(b)(4)]:
SEC Accession No. 0001640334-23-000798
Filing Date
2023-05-10
Accepted
2023-05-10 16:30:31
Documents
3

Document Format Files

Seq Description Document Type Size
1 FORM 424B4 lxrp_424b4.htm 424B4 234045
2 lxrp_s1img3.jpg GRAPHIC 14346
3 lxrp_s1img4.jpg GRAPHIC 14372
  Complete submission text file 0001640334-23-000798.txt   274963
Mailing Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7
Business Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7 250-765-6424
Lexaria Bioscience Corp. (Filer) CIK: 0001348362 (see all company filings)

IRS No.: 202000871 | State of Incorp.: NV | Fiscal Year End: 0831
Type: 424B4 | Act: 33 | File No.: 333-271096 | Film No.: 23906988
SIC: 2834 Pharmaceutical Preparations